Come up with a name for your new list and we'll add to it:
PanCryos raised a round of funding on May 30, 2017. Investors include
Nordic Mentor Network of Entrepreneurship.
PanCryos is a prospective spin out company arising from DanStem, University of Copenhagen, aiming to develop a next generation stem cell derived allogenic cell therapy (PanINSULA) for type 1 diabetes,…